Serum and 24-hour urine analysis in adult cyanotic and noncyanotic congenital heart disease patients

Congenital Heart Disease

Volumn 4, Issue 3, 2009, Pages 147-152

  Martínez Quintana, Efrén ^a   Rodríguez González, Fayna ^a   Fábregas Brouard, Marian ^a   Nieto Lago, Vicente ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

Congenital heart disease; Cyanotic; Impaired renal function; Microalbuminuria; Proteinuria

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM; CREATININE; HEMOGLOBIN; PHOSPHORUS; SODIUM; UREA; URIC ACID;

ADULT; AORTA COARCTATION; AORTA VALVE DISEASE; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DEMOGRAPHY; DISEASE ASSOCIATION; ECHOGRAPHY; EISENMENGER COMPLEX; FALLOT TETRALOGY; FEMALE; GLOMERULUS FILTRATION RATE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DYSFUNCTION; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MICROALBUMINURIA; MITRAL VALVE DISEASE; OXYGEN SATURATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; PULMONARY VALVE STENOSIS; THROMBOCYTE COUNT; URIC ACID BLOOD LEVEL; URINALYSIS;

ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CIRCADIAN RHYTHM; CYANOSIS; FEMALE; HEART DEFECTS, CONGENITAL; HEMATOLOGIC TESTS; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; PREDICTIVE VALUE OF TESTS; URINALYSIS; YOUNG ADULT;

EID: 66649098693     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2009.00273.x     Document Type: Article

References (27)

1. Agras PI, Derbent M, Ozcay F, et al. Effect of congenital heart disease on renal function in childhood. Nephron Physiol. 2005;99:10-15.
2. Iserin L. Cyanotic heart disease in the adult. Arch Mal Coeur Vaiss. 2002;95:1100-1103.
3. Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol. 2006;21:1440-1445.
4. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11(suppl):A08028.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
6. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-147.
7. Dittrich S, Kurschat K, Lange PE. Abnormal rheology in cyanotic congenital heart disease - a factor in non-immune nephropathy. Scand J Urol Nephrol. 2001;35:411-415.
8. Katayama Y, Horigome H, Murakami T, Takahashi-Igari M, Miyata D, Tanaka K. Evaluation of blood rheology in patients with cyanotic congenital heart disease using a microchannel array flow analyzer. Clin Hemorheol Microcirc. 2006;35:499-508.
9. Lill MC, Perloff JK, Child JS. Pathogenesis of thrombocytopenia in cyanotic congenital heart disease. Am J Cardiol. 2006;98:254-258.
10. Dimopoulos K, Diller GP, Koltsida E, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation. 2008;117:2320-2328.
11. Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol. 2000;86:1198-1204.
12. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
13. Fujimoto Y, Matsushima M, Tsuzuki K, et al. Nephropathy of cyanotic congenital heart disease: Clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor. Clin Nephrol. 2002;58:95-102.
14. Dittrich S, Haas NA, Bührer C, Müller C, Dähnert I, Lange PE. Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr. 1998;87:949-954.
15. Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol. 2006;21:1440-1445.
16. Broberg CS, Bax BE, Okonko DO, et al. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol. 2006;48:356-365.
17. Katayama Y, Horigome H, Murakami T, Takahashi-Igari M, Miyata D, Tanaka K. Evaluation of blood rheology in patients with cyanotic congenital heart disease using a microchannel array flow analyzer. Clin Hemorheol Microcirc. 2006;35:499-508.
18. Kajimoto H, Nakazawa M, Murasaki K, et al. Increased thrombogenesity in patients with cyanotic congenital heart disease. Circ J. 2007;71:948-953.
19. McQueen MJ. Evidence for the use of urinary albumin as marker of kidney involvement in unselected populations. Scand J Clin Lab Invest Suppl. 2008;241:52-56.
20. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307-1315.
21. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004;351:1285-1295.
22. Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc. 2008;83:806-812.
23. Zamora CR, Cubeddu LX. Microalbuminuria: Do we need a new threshold? J Hum Hypertens. 2009;23:146-149.
24. Galle J. Reduction of proteinuria with angiotensin receptor blockers. Nat Clin Pract Cardiovasc Med. 2008;5(suppl 1):S36-43.
25. Halimi JM, Hadjadj S, Aboyans V, et al. French Society of Nephrology. Microalbuminuria and urinary albumin excretion: French guidelines. Ann Biol Clin (Paris). 2008;66:277-284.
26. Hayabuchi Y, Matsuoka S, Akita H, Kuroda Y. Hyperuricaemia in cyanotic congenital heart disease. Eur J Pediatr. 1993;152:873-876.
27. Singh GR, White AV, Hoy WE. Renal ultrasound findings in an Australian Aboriginal population with high rates of renal disease. Nephrology (Carlton). 2005;10:358-361.